This research was performed To guage the opportunity in the CPPs with tumor-concentrating on Qualities to deliver a cytotoxic payload to HCC cells. We explored employing a CXCR4-targeting peptide, T22, fused with cytotoxic peptide PE24, to be a novel therapeutic tactic for CXCR4+ HCC cells. T22 was decided on given https://atecan074nru4.blognody.com/profile